These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37641433)

  • 1. The role of intermolecular interactions on monoclonal antibody filtration through virus removal membranes.
    Billups M; Minervini M; Holstein M; Feroz H; Ranjan S; Hung J; Zydney AL
    Biotechnol J; 2023 Dec; 18(12):e2300265. PubMed ID: 37641433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of membrane structure on the filtrate flux during monoclonal antibody filtration through virus retentive membranes.
    Billups M; Minervini M; Holstein M; Feroz H; Ranjan S; Hung J; Bao H; Li ZJ; Ghose S; Zydney AL
    Biotechnol Prog; 2022 Mar; 38(2):e3231. PubMed ID: 34994527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Analysis of the Impact of Protein on Virus Retention for Different Virus Removal Filters.
    Afzal MA; Peles J; Zydney AL
    Membranes (Basel); 2024 Jul; 14(7):. PubMed ID: 39057666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of protein fouling on filtrate flux and virus breakthrough behaviors during virus filtration process.
    Suh D; Jin H; Park H; Lee C; Cho YH; Baek Y
    Biotechnol Bioeng; 2023 Jul; 120(7):1891-1901. PubMed ID: 37144573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fouling of virus filtration membranes by monoclonal antibody feeds with low aggregate content.
    Kaufman Y; Hunt KC; Hale G; McClure M; Latulippe D; Sivan M; Wilson J; Dorin R; Agroskin Y; Siwak M; Gerion D
    Biotechnol Bioeng; 2024 Aug; 121(8):2400-2408. PubMed ID: 37163237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of protein fouling on nanoparticle capture within the Viresolve® Pro and Viresolve® NFP virus removal membranes.
    Fallahianbijan F; Giglia S; Carbrello C; Bell D; Zydney AL
    Biotechnol Bioeng; 2019 Sep; 116(9):2285-2291. PubMed ID: 31081123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein fouling during constant-flux virus filtration: Mechanisms and modeling.
    Peles J; Cacace B; Carbrello C; Giglia S; Zydney AL
    Biotechnol Bioeng; 2023 Nov; 120(11):3357-3367. PubMed ID: 37489799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of viral filtration performance of monoclonal antibodies based on biophysical properties of feed.
    Rayfield WJ; Roush DJ; Chmielowski RA; Tugcu N; Barakat S; Cheung JK
    Biotechnol Prog; 2015; 31(3):765-74. PubMed ID: 25919945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leveraging bioanalytical characterization of fractionated monoclonal antibody pools to identify aggregation-prone and less filterable proteoforms during virus filtration.
    Isu S; Vinskus L; Silva D; Cunningham K; Elich T; Greenhalgh P; Sokolnicki A; Raghunath B
    Biotechnol Prog; 2024; 40(4):e3451. PubMed ID: 38450976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virus filtration of high-concentration monoclonal antibody solutions.
    Marques BF; Roush DJ; Göklen KE
    Biotechnol Prog; 2009; 25(2):483-91. PubMed ID: 19353736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An alternative assay to hydrophobic interaction chromatography for high-throughput characterization of monoclonal antibodies.
    Estep P; Caffry I; Yu Y; Sun T; Cao Y; Lynaugh H; Jain T; Vásquez M; Tessier PM; Xu Y
    MAbs; 2015; 7(3):553-61. PubMed ID: 25790175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of flux on the clearance of minute virus of mice during constant flux virus filtration.
    Fan R; Namila F; Sansongko D; Wickramasinghe SR; Jin M; Kanani D; Qian X
    Biotechnol Bioeng; 2021 Sep; 118(9):3511-3521. PubMed ID: 33811657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adapting virus filtration to enable intensified and continuous monoclonal antibody processing.
    Bohonak DM; Mehta U; Weiss ER; Voyta G
    Biotechnol Prog; 2021 Mar; 37(2):e3088. PubMed ID: 33016523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limits in virus filtration capability? Impact of virus quality and spike level on virus removal with xenotropic murine leukemia virus.
    Roush DJ; Myrold A; Burnham MS; And JV; Hughes JV
    Biotechnol Prog; 2015; 31(1):135-44. PubMed ID: 25395156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrafiltration behavior of monoclonal antibodies and Fc-fusion proteins: Effects of physical properties.
    Baek Y; Singh N; Arunkumar A; Borys M; Li ZJ; Zydney AL
    Biotechnol Bioeng; 2017 Sep; 114(9):2057-2065. PubMed ID: 28464237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving viral filtration capacity in biomanufacturing processes using aggregate binding properties of polyamide-6,6.
    Stanevich V; Pachalla A; Nunez B; McInnes M; Nieder C; Schreffler J
    Biotechnol Bioeng; 2021 Mar; 118(3):1105-1115. PubMed ID: 33241852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of fouling mechanisms of virus filters during the filtration of protein solutions using a high throughput filtration screening device.
    Bieberbach M; Kosiol P; Seay A; Bennecke M; Hansmann B; Hepbildikler S; Thom V
    Biotechnol Prog; 2019 Jul; 35(4):e2776. PubMed ID: 30629862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rational design of viscosity reducing mutants of a monoclonal antibody: hydrophobic versus electrostatic inter-molecular interactions.
    Nichols P; Li L; Kumar S; Buck PM; Singh SK; Goswami S; Balthazor B; Conley TR; Sek D; Allen MJ
    MAbs; 2015; 7(1):212-30. PubMed ID: 25559441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Online coupling of analytical hydrophobic interaction chromatography with native mass spectrometry for the characterization of monoclonal antibodies and related products.
    Yan Y; Xing T; Wang S; Daly TJ; Li N
    J Pharm Biomed Anal; 2020 Jul; 186():113313. PubMed ID: 32371326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of pH, NaCl concentration, and mAb concentration of feed solution on the filterability of Planova™ 20N and Planova™ BioEX.
    Hashikawa-Muto C; Yokoyama Y; Hamamoto R; Kobayashi K; Masuda Y; Nonaka K
    Biotechnol Prog; 2024; 40(2):e3420. PubMed ID: 38146091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.